Aimei Health Technology Co Unit
AFJKU
6 hedge funds and large institutions have $2.93M invested in Aimei Health Technology Co Unit in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.99% less ownership
Funds ownership: 4.08% → 3.09% (-0.99%)
25% less capital invested
Capital invested by funds: $3.9M → $2.93M (-$971K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$557K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$263 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
-$1.54M |
AFJKU Hedge Fund Activity: Q2 2024 in Review
6 of the 6,937 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Co Unit (AFJKU) for Q2 2024, worth a combined $2.93M — down 25% from $3.9M a quarter earlier.
Fund positioning in AFJKU was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $557K. The largest seller was Sandia Investment Management, exiting entirely with an estimated $1.54M sold.
- 6 institutional investors held Aimei Health Technology Co Unit (AFJKU) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $2.93M of Aimei Health Technology Co Unit stock for Q2 2024, down 25% quarter-over-quarter.
- 1 fund opened new Aimei Health Technology Co Unit positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Aimei Health Technology Co Unit buyer in Q2 2024 was Shaolin Capital Management, an estimated $557K added.
- The largest Aimei Health Technology Co Unit seller in Q2 2024 was Sandia Investment Management, an estimated $1.54M sold.
Based on aggregated 13F filings for Q2 2024.